I am about to meet the CEO and co-founder of a #techbio company that I admire immensely. It's literally a dream come true🤩. Just a year ago, it was just me and my crazy ideas. Today it's Karl-Oskar, me, and a bunch of other amazing people with OUR crazy ideas, all united under Elnora AI. During this time, we have built the first version of Elnora's platform, started a pilot with TalTech – Tallinn University of Technology, secured our first investments, and built an amazing team. But to me, personally, the greatest achievement so far is that I am about to meet a person who has inspired me from the other side of the world without even knowing it. Today he knows me and our company's name, and very soon we will meet in person! Chris Gibson - here I come! 🚀
About us
The journey to bring a new drug from concept to market takes over 10 years, costs 2.5B dollars, and faces a failure rate of over 90%. Target identification is the first and most crucial step in drug discovery, influencing the probability of success at every subsequent step of drug development. We have hundreds of thousands of potential targets and their combinations to choose from, but determining the right one for a specific disease remains a challenge. To address this, we tap into the primary source of data: academic researchers. Elnora AI is revolutionizing drug discovery by harnessing the power of AI and the academic research community. This approach accelerates the R&D process, makes it faster, more cost-effective, and more reliable by avoiding repeated mistakes. Our platform collects ML-readable, detailed data on experiment conditions and outcomes. This includes failed experiments, repeated trials under various conditions, and studies conducted worldwide. We also extract data from publicly available datasets and scientific papers, integrating it with researchers' raw data. Subsequently, we feed this comprehensive dataset into our AI models to identify the fastest, most efficient path to groundbreaking discoveries. Elnora can replicate the process of finding novel drug targets likely to succeed in subsequent phases of development. By combining public and proprietary datasets, we can predict success scores for each s in the identification of a viable drug target. As a techbio company guided by triple bottom line principles and driven by a mission to have a real impact, we are leveraging the Elnora platform ourselves to chart a new course in antiviral drug discovery. While thousands of viruses threaten human health, the antiviral drug solutions are limited. Our unique approach focuses on host cells rather than directly targeting viruses, offering potential resistance to viral mutations and broad-spectrum efficacy against a range of viral strains.
- Website
-
https://www.elnora.ai
External link for Elnora AI
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Tallinn
- Type
- Self-Employed
- Founded
- 2023
- Specialties
- Artificial Intelligence, Drug Development, Antiviral Drugs, Pharmaceutical, BioPharma, Drug Discovery, AI Drug Discovery, DeepTech, HealthTech, Technology, and TechBio
Locations
-
Primary
Tallinn, EE
Employees at Elnora AI
-
Darya Kamkalova
Founder of Venturing Women • Angel Investor • Podcast Host • Speaker • Moderator • Community Builder
-
Anna-Liisa Reinson
Visiting Product Lead | Product Mentor | ex-E-Residency, ex-Telia
-
Mihkel Heinmaa
Software Developer at Pipedrive
-
Karl-Oskar Masing
CTO & Co-founder of Elnora AI | I've built too many machine learning powered systems
Updates
-
🎯 What is BiPO? The first product from Elnora AI, #BiPO (Biomedical Protocol Organizer), helps researchers optimize lab protocols to ensure they work the first time. Key challenges #BiPO solves: 💡Tackles poor experimental design, lack of data sharing, and the reproducibility crisis. 💡Captures both positive and negative experimental outcomes, addressing the bias in scientific publishing. 💡Reduces unnecessary duplication of experiments, especially redusing the number of animals used in testing. How #BiPO transforms research: 🚀 Standardizes protocols and data sharing: researchers can easily access and learn from past experiments, whether successful or not. 🚀 Improves efficiency: saves time and resources by optimizing protocols and minimizing research waste and cost. 🚀 Promotes collaboration: BiPO encourages a collaborative research culture. 🚀 Democratizes access to high-quality research tools: enables smaller organizations access the same tools as large institutions. 🌍 The change we want to create with #BiPO is to establish data sharing as a standard practice and measure impact through practical applications rather than citations. BiPO's AI/ML-ready format ensures data integrity while making it easier for scientists worldwide to find information, optimize protocols, and build collaborations. Most notably, it will democratize science by giving everyone access to the same knowledge and the tools to put that knowledge into action. And now comes the most important part... 🥁 Elnora AI leads by example. We are the change. That’s why I’m incredibly proud to present a multinational consortium, made up of 6 countries across two continents, with whom we are collaborating to bring #BiPO to researchers worldwide. Every Tuesday for the past four weeks, I’ve had the pleasure of working with these brilliant minds, and each time I am amazed by the exceptional talent we’ve managed to bring together. Just 1.5 months ago, this was only an idea—to bring diversity and different perspectives into the development stage. Now, this idea has sparked something truly special that we plan to continue building for years to come. P.S. Unfortunately, not everyone fit into the picture, but I’ll capture a new one once I figure out how to show everyone! THANK YOU us for being so awsome! Carmen Kivisild, Karl-Oskar Masing, Anna-Liisa Reinson, Robert Golabek, Patryk Golabek, Erle Raudsepp, Katariina Pajuranta, Udayanto Dwi Atmojo, Filipe Coelho, Simão Ferreira, Monica Vieira, Bruno Alves Ribeiro, Zita Vale, Pedro Faria, Simona Brezar, Safinaz Ö., Mesut Nadir Seyfelioglu, Setenay Gemici, UTKU ÇOLAK, Ufuk Cem Çakır, Şeyma Gözüyılmaz, Mehmet Hakkı Ersoy, Rodney Kadadi, Gürkan Şahin, PhD(c)
-
This is a great opportunity to see one of our co-founders, Carmen Kivisild to step on the stage and tell her story! :)
Attention to all VCs in my network! Now’s your chance to meet me in person and chat about the future rounds of Elnora AI. Joining the Startup Lithuania accelerator powered by Plug and Play Europe and was an excellent decision, and I’m very pleased with the program because the people behind it are incredibly good. What makes the Plug and Play team special is that they genuinely believe in you and support you in every way they can. No request is too much for them. There have been numerous times when I’ve reached out to the team late in the evening, and they were there to take the urgent call. I send a WhatsApp message, and they reply within minutes. I rant about my hard week, and they listen. I ask for honest answers, and they provide them. The team is truly a pleasure to work with. Thank you Anastasija Hadunkina, Povilas Žinys, Carolin Wais. But back to the main point. The program is coming to an end, and they’re organizing a huge #ExpoDay. Many great people and startups will attend, and I’m inviting you to join the event! First, you can see me pitch live and meet me in person, plus you'll get to see all the other amazing startups that have participated in the program. AND if you’re a startup yourself, this is the BEST opportunity to meet the team and secure a spot for the next batch. Many great things have already come out of this accelerator, and many more will continue. Although the program may be ending, our work together is just beginning. Come and join us! https://lnkd.in/djKieDWu
-
Thank you to The Center for Advancing Innovation Inc. for selecting us as one of the winners of the Global Health Innovation Challenge II. It is truly an honor to be named alongside these other great companies solving big problems in health. We can't fix the world alone, but together we can make a difference.
CAI is delighted to announce the winners of our Global Health Innovation Challenge II (GHIC II). Funded and orchestrated by CAI with continued support from the U.S. Economic Development Administration #BuildtoScale Program and CAI's Advocate network, these companies have joined an entrepreneurial community that has raised >$2 billion and directly created 2000+ jobs since 2015. Congratulations to the winners! Learn more at https://lnkd.in/gM5Dbj8U. 👀
The Center for Advancing Innovation Names Global Health Innovation Challenge II Winners Catalyzing the Future of Health - IssueWire
issuewire.com
-
We're proud to be named one of the TOP-80 finalists at Health Tech Challengers this year! Catch us in action as we pitch live in Barcelona, on December 4-5, 2024. See you there! 🇪🇸 #HTF2024 #HTC2024 https://lnkd.in/dMqQnREz
-
Thank you, Health Tech Challengers, for the opportunity to come to Barcelona and share Elnora's vision on how we are lowering the 90% failure rate in drug discovery. 🤩 It will be epic! 🚀
For our TechBio track, we sought startups accelerating drug discovery and clinical trials. We asked for bold ideas – and these startups delivered. 🖤 Meet the finalists of the TechBio track (in alphabetical order): ▪️ AICURA medical GmbH ▪️ aimed analytics GmbH ▪️ BIORCE ▪️ Elnora AI ▪️ Monsana ▪️ Pharmacelera ▪️ PrecisionLife ▪️ PURR.AI ▪️ Qureight ▪️ TrialHub Congrats to all the finalists! Join Health Tech Forward on December 4-5 to hear these startups pitch live. 👉 healthtechforward.com
-
Thank you so much for your support Tehnopol HealthTech.
🚀 Elnora AI tähistab oma esimest tegutsemisaastat suurepäraste uudistega! Nad kaasasid edukalt ligi 95 000 eurot Boost VC ja Plug and Play Tech Centerilt, mis suunatakse tootearendusse, et tuua veel sel aastal oma platvorm avalikkuse ette. Lisaks sellele osaleb Elnora mõlema kiirendi programmides, mis toovad kaasa võimaluse liikuda Silicon Valley'sse – unistus, mille poole ettevõte on alati püüelnud. 👏 Elnora AI esimene toode on labori protokollide optimeerija, mis võimaldab teadlastel ja biotehnoloogiaettevõtetel oma protokolle AI abil täiustada. „See on nagu labori co-pilot,” selgitab asutaja Carmen Kivisild. Nende visioon on muuta laborite töö kiiremaks ja tõhusamaks, vähendades ravimite väljatöötamise läbikukkumise tõenäosust. Tulevik paistab paljulubav – lähiajal alustatakse TalTechis uut pilootprojekti ning kaks koostööprojekti on veel läbirääkimiste faasis. Üks neist on seotud riigiasutusega ja teine biotehnoloogia eraettevõttega. Elnora AI näitab, kuidas saab ambitsioonid ellu viia vaid aastaga! Palju edu Carmen, Karl-Oskar Masing ja teised uute projektidega nii Eestis, Euroopas kui ka kaugemal! 🌍💡 #ElnoraAI #Tehnopol #HealthTech #Innovation #SiliconValley #AI
-
Our team has worked hard turning this summer and we have loads of exciting news to share. Here is the first one! Elnora AI is part of Startup Lithuania Accelerator powered by Plug and Play Tech Center - Batch 2 🤩 Great things are ahead!
Exciting news! Today is the official launch of the Startup Lithuania Accelerator powered by Plug and Play - Batch 2! It's my honour to announce the best of the best. Suspense suspense 💡 Here they are: ⭐️Amia ⭐️Traxlo ⭐️DiaWiser ⭐️Playground City ⭐️Hoperfy ⭐️Askflow AI ⭐️Vespia ⭐️Pointai ⭐️peoplerank ⭐️Scalier ⭐️Markster ⭐️Greet ⭐️Miniatura ⭐️Elnora AI A heartfelt thank you to Vice-Minister of Economy Karolis Žemaitis and Head of Startup Lithuania Karolina Urbonaitė for joining the event as speakers. None of this would have been possible without the invaluable support from the Lithuania Ministry of Economy and Innovation and Innovation Agency Aušra Grikšaitė. Huge kudos to our dedicated team on the ground Anastasija Hadunkina Andrej Fadejev gratitude to our organization at both the EMEA and global levels for their unwavering support. Leonardo Rocchetti Carolin Wais, Virginia Rios and many more. Let's take a deep breath cause we're just getting started. #plugandplay #acceleratorlaunch #startuplithuania
-
Elnora AI reposted this
The first cohort of the Baltic Impact Accelerator is nearing its grand finale! 🎬 To celebrate and showcase their incredible work, 28 accelerator teams from Estonia, Latvia, Finland, and Sweden will pitch their ideas at Demo Day on June 20th from 10 AM to 3 PM (EET). Participants from Estonia include: Recicletool 👉🏼 Develops reverse vending machines and other equipment for collecting and separating packaging for the correct final destination and reducing the use of packaging. WNWN.skin 👉🏼 Valorization of fruit and vegetable farm byproduct plant biomass into bioferments for cosmeceutical industry. IVA AI 👉🏼 Empowering small businesses to scale their sales team quickly and efficiently through use of digital employees. Elnora AI 👉🏼 Revolutionizing antiviral drug discovery by harnessing the power of artificial intelligence. Ecolife.com 👉🏼 Revolutionizing sustainable fashion with its marketplace that reduces users consumption impact. FudLoop 👉🏼 Save food from getting thrown away by distributing to our clients through an innovative food locker system. If you are interested in joining us online as an investor or a guest, please fill out this form 📩 https://lnkd.in/dP5efgia - This event is implemented within the Interreg Central Baltic Programme Project “Triple Bottom Line Baltic Impact Accelerator” ID. CB0100053. Green Tech Cluster Latvia, LUT University, Sustainability InnoCenter Baltic Impact Accelerator in Estonia is supported by Luminor Eesti. #luminor
-
🚀 Our pre-seed round is in full swing with strong interest from #VCs! But we don't stop there. The show must go on, and today Carmen Kivisild will be pitching on the EBAN - European Business Angel Network Annual Congress stage followed by 1:1 meetings with all the cool VCs attending the congress and Latitude59. 🎥 Here's our video pitch to give you a taste of what we're building at Elnora AI. 📍 If you're in #Estonia this week, hit us up and let's chat! #Startup #Fundraising #AI #DrugDiscovery #Latitude59 #EBAN #ElnoraAI